IL17A and gastric carcinoma: The results of our study demonstrate that significantly elevated IL-17 levels are observed in patients with gastric carcinoma detected at an early stage, whereas systemic concentrations of this cytokine in individuals with advanced disease are comparable to the values observed in healthy controls.